New user?
Also registered?
Dapizo is an inhibitor of Sodium Glucose Trasport Protein – 2(SGLT2). By inhibiting the transport protein (SGLT2) in the kidneys, it reduces renal glucose reabsorption, leading to urinary glucose excretion and a reduction in blood glucose levels. In patient with Heart Failure and Reduced Ejection Fraction (40% or less), the risk of worsening heart failure or death from cardiovascular causes was lower among those who received Dapagliflozin.
Dapizo is an inhibitor of Sodium Glucose Trasport Protein – 2(SGLT2). By inhibiting the transport protein (SGLT2) in the kidneys, it reduces renal glucose reabsorption, leading to urinary glucose excretion and a reduction in blood glucose levels. In patient with Heart Failure and Reduced Ejection Fraction (40% or less), the risk of worsening heart failure or death from cardiovascular causes was lower among those who received Dapagliflozin.
Reviews
There are no reviews yet.